(Q37751892)

22 August 2017

1 reference

title

The p53 tumour suppressor gene (English)

1 reference

22 August 2017

Levine AJ

1 reference

22 August 2017

Momand J

series ordinal

1 reference

22 August 2017

Finlay CA

series ordinal

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 June 1991

1 reference

22 August 2017

1 reference

inferred from page(s)

published in

Nature

1 reference

22 August 2017

volume

351

1 reference

22 August 2017

issue

6326

1 reference

22 August 2017

page(s)

453-456

1 reference

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

22 August 2017

cites work

1 reference

7 January 2021

T antigen is bound to a host protein in SY40-transformed cells

1 reference

7 January 2021

Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse

1 reference

7 January 2021

The SV40 a gene product is required for the production of a 54,000 MW cellular tumor antigen

1 reference

7 January 2021

Post-Translational Regulation of the 54K Cellular Tumor Antigen in Normal and Transformed Cells

1 reference

7 January 2021

Two Distinct Mechanisms Regulate the Levels of a Cellular Tumor Antigen, p53

1 reference

7 January 2021

Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53

1 reference

7 January 2021

Participation of p53 cellular tumour antigen in transformation of normal embryonic cells

1 reference

7 January 2021

Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

1 reference

7 January 2021

The p53 proto-oncogene can act as a suppressor of transformation

1 reference

7 January 2021

Wild-type p53 can inhibit oncogene-mediated focus formation

1 reference

7 January 2021

Suppression of human colorectal carcinoma cell growth by wild-type p53

1 reference

7 January 2021

p53 functions as a cell cycle control protein in osteosarcomas

1 reference

7 January 2021

Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

1 reference

7 January 2021

Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein

1 reference

7 January 2021

Genetic mechanisms of tumor suppression by the human p53 gene

1 reference

7 January 2021

Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus

1 reference

7 January 2021

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

1 reference

7 January 2021

Mutations in the p53 gene occur in diverse human tumour types

1 reference

7 January 2021

1 reference

7 January 2021

p53: a frequent target for genetic abnormalities in lung cancer.

1 reference

7 January 2021

Increased expression of mutant forms of p53 oncogene in primary lung cancer

1 reference

7 January 2021

Mitotic recombination of chromosome 17 in astrocytomas

1 reference

7 January 2021

Allele loss on short arm of chromosome 17 in breast cancers

1 reference

7 January 2021

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

7 January 2021

High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene

1 reference

7 January 2021

Different tumor-derived p53 mutants exhibit distinct biological activities

1 reference

7 January 2021

Monoclonal antibody analysis of p53 expression in normal and transformed cells

1 reference

7 January 2021

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

1 reference

7 January 2021

Presence of a potent transcription activating sequence in the p53 protein

1 reference

7 January 2021

Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport

1 reference

7 January 2021

Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells

1 reference

7 January 2021

Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

1 reference

7 January 2021

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells

1 reference

7 January 2021

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

1 reference

7 January 2021

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

1 reference

7 January 2021

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene

1 reference

7 January 2021

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

1 reference

7 January 2021

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

1 reference

7 January 2021

Mouse p53 inhibits SV40 origin-dependent DNA replication

1 reference

7 January 2021

p53 and DNA polymerase alpha compete for binding to SV40 T antigen

1 reference

7 January 2021

The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen

1 reference

7 January 2021

Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells

1 reference

7 January 2021

Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines

1 reference

7 January 2021

p53 mutations in colorectal cancer

1 reference

7 January 2021

Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis

1 reference

7 January 2021

Mechanisms of p53 loss in human sarcomas

1 reference

7 January 2021

Identifiers

DOI

10.1038/351453A0

1 reference

Dimensions Publication ID

22 August 2017

1052393971

0 references

1 reference